Skip to main content
    C

    Cingulate Inc (CING)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.75
    -0.55 (-12.79%)

    Market Cap: $62.53M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Cingulate Inc (CING) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Cingulate reported EPS of -$0.53, below the -$0.48 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    40%(8/20)
    Avg Surprise
    -12.13%

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.35
    Range-$0.58 - $0.05
    8 analysts
    Revenue Consensus
    $2.40M
    RangeN/A
    7 analysts

    Next Report

    CING's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 20 quarters below that had an estimate, CING beat 8 and missed 12. The widest gap in the table came in the quarter ended Mar 31, 2022, when EPS landed 87.23% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.53-$0.48-$0.55 - -$0.39-10.42%MissN/A32 up, 1 downNov 13, 2026
    Jun 30, 2026-$0.45-$0.63-$0.77 - -$0.33+28.57%BeatN/A31 up, 1 downAug 13, 2026
    Mar 31, 2026-$0.95-$0.53-$0.74 - -$0.38-79.25%MissN/A33 up, 0 downMay 14, 2026
    Dec 31, 2025-$0.84-$1.55-$4.32 - -$0.38+45.81%BeatN/A41 up, 2 downMar 18, 2026
    Sep 30, 2025-$1.35-$0.75-$0.96 - -$0.53-80.00%MissN/A51 up, 2 downNov 13, 2025
    Jun 30, 2025-$1.09-$0.82-$0.90 - -$0.62-32.93%MissN/A40 up, 1 downAug 19, 2025
    Mar 31, 2025-$1.04-$0.98-$1.00 - -$0.96-6.12%MissN/A21 up, 0 downMay 8, 2025
    Dec 31, 2024-$3.68-$2.93N/A-25.60%MissN/A31 up, 0 downMar 27, 2025
    Sep 30, 2024-$1.83-$2.22-$3.03 - -$1.41+17.57%BeatN/A30 up, 0 downNov 7, 2024
    Jun 30, 2024-$5.47-$4.92-$6.36 - -$4.92-11.18%MissN/A20 up, 0 downAug 13, 2024
    Mar 31, 2024-$19.20-$52.72N/A+63.58%BeatN/A21 up, 0 downMay 8, 2024
    Dec 31, 2023-$7.66-$4.86-$6.26 - -$2.60-57.61%MissN/A40 up, 0 downMar 29, 2024
    Sep 30, 2023-$72.00-$90.40-$117.65 - -$57.62+20.35%BeatN/A40 up, 0 downNov 13, 2023
    Jun 30, 2023-$136.80-$81.60-$91.24 - -$72.03-67.65%MissN/A30 up, 0 downAug 14, 2023
    Mar 31, 2023-$84.00-$77.60-$110.44 - -$57.62-8.25%MissN/A40 up, 0 downMay 10, 2023
    Dec 31, 2022-$0.41-$0.37-$0.45 - -$0.25-10.81%MissN/A40 up, 0 downMar 10, 2023
    Sep 30, 2022-$86.40-$88.80-$91.24 - -$86.43+2.70%BeatN/A20 up, 0 downNov 14, 2022
    Jun 30, 2022-$86.40-$139.20N/A+37.93%BeatN/A10 up, 0 downAug 11, 2022
    Mar 31, 2022-$105.60-$56.40-$57.62 - -$55.22-87.23%MissN/A20 up, 0 downMay 12, 2022
    Dec 31, 2021-$0.32-$0.39-$0.39 - -$0.39+17.95%BeatN/A10 up, 0 downMar 10, 2022
    Sep 30, 2021-$1.38N/AN/AN/AN/AN/AN/AN/ADec 9, 2021
    Jun 30, 2021-$0.35N/AN/AN/AN/AN/AN/AN/ASep 27, 2021
    Last 22 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.32, after -$30.18 the year before. It was -$2.05 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.32N/A
    Dec 31, 2024-$30.18N/A
    Dec 31, 2023-$300.46N/A
    Dec 31, 2022-$278.81N/A
    Dec 31, 2021-$2.05N/A

    Frequently Asked Questions About CING

    Did CING beat earnings estimates last quarter?

    No. Cingulate reported EPS of -$0.53 for the quarter ended Sep 30, 2026, below the -$0.48 estimate by 10.42%.

    What EPS do analysts expect from CING next quarter?

    The consensus EPS estimate for Cingulate for the quarter ending Dec 31, 2026 is -$0.35 from 8 analysts, with estimates from -$0.58 to $0.05.

    How often does CING beat earnings estimates?

    Cingulate beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -19.99%.